PHILADELPHIA (WPVI) -- It's the only authorized treatment that can help keep people with COVID-19 out of the hospital, but hundreds-of-thousands of doses aren't being used. The effectiveness of ...

Apr. 15—The Henry Ford Health System is receiving additional supplies of monoclonal antibodies from the federal government in an effort to hold down COVID-19 hospitalizations that are threatening to ...

While doctors have stressed the importance of COVID-19 vaccinations, there are also coronavirus treatments helping sick patients stay out of the hospital. Monoclonal antibody therapy is gaining ...

Editor's note: Find the latest COVID-19 news and guidance in Medscape's Coronavirus Resource Center. New research suggests that the casirivimab-imdevimab monoclonal antibody treatment for COVID-19 ...

The FDA issued an emergency use authorization (EUA) for pemivibart (Pemgarda) as COVID-19 pre-exposure prophylaxis in immunocompromised individuals who are unlikely to mount a sufficient immune ...

The dominance of the Delta strain of COVID-19 combined with Alabama’s low vaccination rate has led experts to turn to monoclonal antibody infusion, a treatment in which infected individuals are ...

New protection against COVID-19 is now available for a group of people who need it the most – those who are moderately or severely immunocompromised. The U.S. Food and Drug Administration has ...

Coastal Pediatric Associates (CPA) has opened the Antibody Infusion Clinic for high risk, medically complex children and young adults ages 12 and older who test positive for COVID-19, but do not meet ...

If you’re older than 12 and test positive for COVID-19, you most likely qualify to receive monoclonal antibody treatment on Texas’ dime. For most, the largest barrier to getting the early-stage ...

Oct. 29—LENOIR — The Caldwell County Health Department (CCHD) has partnered with the county's Community Paramedics to provide Monoclonal Antibody Infusion Therapy, a treatment for COVID-19 positive ...

A Statistical Immune Correlates of Protection Model for Predicting Efficacy from Neutralizing Antibody Titers to Establish Immunobridging of Monoclonal Antibodies for Prevention of COVID-19” was ...